Today: 9 May 2026
Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
1 January 2026
1 min read

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

NEW YORK, January 1, 2026, 09:31 ET — Market closed.

  • Apple shares ended the last session down $1.22, or 0.45%, at $271.86 as 2025 wrapped up.
  • U.S. stocks fell in holiday-thin trading into the New Year’s Day closure, weighing on big tech.
  • Investors are now watching early-January U.S. data, the late-January Fed meeting and Apple’s expected earnings date.

Apple Inc (AAPL.O) shares slipped $1.22, or 0.45%, to close at $271.86 on Wednesday, the final trading day of 2025. U.S. markets are shut on Thursday for the New Year’s Day holiday.

The move matters because it leaves Apple starting 2026 with investors rotating around megacap tech after a late-December pullback. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide. Reuters

Trading stayed light into the holiday, a backdrop that can amplify moves when large investors step away. The S&P 500 fell 0.74% and the Nasdaq dropped 0.76% on Wednesday, with technology among the weakest groups, Reuters reported.

Apple’s decline left the stock roughly 5.8% below its 52-week high of $288.62 and near its 50-day moving average of $272.47, a widely watched trend gauge. Yahoo Finance data show Apple is up about 12% over the past 52 weeks.

A separate Apple headline surfaced late Wednesday when the company teased “big” updates planned for 2026 for its Fitness+ subscription service in an Instagram post, without providing details. Business Insider

The year-end slide came even as Wall Street booked strong annual gains in 2025, with the S&P 500 up 16.39% and the Nasdaq up 20.36%, according to Reuters. Apple’s heavy weighting means even modest moves can influence major indexes.

Before the next session, regular trading is set to resume on Friday, Jan. 2, after Thursday’s holiday closure.

On the macro front, markets are heading into a data-heavy January, led by the U.S. December employment report on Jan. 9 and the December CPI report on Jan. 13, according to the Bureau of Labor Statistics schedule.

The Federal Reserve’s next rate-setting meeting is scheduled for Jan. 27-28, a focal point for technology valuations that tend to be sensitive to interest-rate expectations.

For Apple, attention turns to the company’s next results, which market calendars currently flag for Jan. 29 after the close, though that date is listed as an estimate. Investors will be focused on holiday-quarter demand signals, Services revenue trends and management’s outlook for early 2026.

Stock Market Today

  • Morgan Stanley Lowers Gilead Sciences Price Target Amid Mixed Analyst Ratings
    May 9, 2026, 10:30 AM EDT. Morgan Stanley cut Gilead Sciences' (NASDAQ:GILD) price target from $175 to $168, signaling a pessimistic outlook despite a potential 27.92% upside. Other firms show mixed sentiment: Goldman Sachs raised target to $130 with a neutral rating, while Bank of America and Citigroup issued buy ratings with targets above $160. Gilead's recent quarterly earnings beat expectations, reporting $2.03 EPS versus $1.91 estimated and revenue of $6.96 billion. The stock trades near $131.33 with a market cap of $163 billion and a P/E ratio of 17.89. CEO Daniel O'Day sold 10,000 shares recently, indicating insider activity amid this uncertain environment. Overall consensus rating remains moderate buy with an average target price of $157.15.

Latest article

Hims & Hers Stock (HIMS) Faces a GLP-1 Test as Q1 Earnings Loom

Hims & Hers Stock (HIMS) Faces a GLP-1 Test as Q1 Earnings Loom

9 May 2026
Hims & Hers Health shares rose 10.2% to $28.27 on Friday ahead of first-quarter results due Monday. Analysts expect Q1 revenue near $616.9 million and earnings of 3 cents per share. The company recently reached a deal with Novo Nordisk to offer Ozempic and Wegovy, and added Eli Lilly’s Zepbound and Foundayo to its platform. The FDA is considering tighter rules on compounding GLP-1 drugs.
Trump Media & Technology Group’s $406 Million Loss Puts DJT Stock Back Under the Microscope

Trump Media & Technology Group’s $406 Million Loss Puts DJT Stock Back Under the Microscope

9 May 2026
Trump Media & Technology Group posted a $405.9 million first-quarter net loss on $871,200 in sales, driven by $244 million in unrealized crypto losses and $108.2 million in investment losses. The company ended March with $2.2 billion in assets, including 9,542 bitcoin and 756 million Cronos tokens. Cash from operations totaled $17.9 million. DJT shares closed at $8.93 Friday, valuing the firm at $2.48 billion.
Seagate Stock Rides AI Storage Boom as STX Rally Faces a Valuation Test

Seagate Stock Rides AI Storage Boom as STX Rally Faces a Valuation Test

9 May 2026
Seagate shares closed at $782.64 Friday, near record highs, as investors bet on rising demand for hard drives in AI-driven data storage. The company last reported fiscal Q3 revenue of $3.11 billion and forecast Q4 revenue of $3.45 billion. Morgan Stanley raised its price target to $767, citing strong pricing and earnings. Seagate’s market value stood at $179.2 billion with a P/E ratio near 74.
Nike stock jumps after CEO Elliott Hill’s $1 million buy — what’s next for NKE
Previous Story

Nike stock jumps after CEO Elliott Hill’s $1 million buy — what’s next for NKE

Social Security COLA 2026 payments start now — January schedule, Medicare premium rise and $6,000 senior tax break
Next Story

Social Security COLA 2026 payments start now — January schedule, Medicare premium rise and $6,000 senior tax break

Go toTop